Figure 1From: Genetic modulation of the interleukin 6 (IL-6) system in patients with advanced gastric cancer: a background for an alternative target therapy Survival analysis with distribution of patients according to rs1800795 genotypes (Panel A) and rs8192284 genotypes (Panel B). Back to article page